Home > Products > CD44 & CR3 > Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (scIgG)

Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (scIgG)  (SCIGG-121)

Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD44 and anti-CR3 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can recruit macrophages to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.

Specifications
Targets
CD44 & CR3
Type
Single chain IgGs
Species Reactivity
Human
Target 1
CD44
Host Animal 1
Mouse
Target 2
CR3
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Glioblastoma; Squamous cancer
Targets
Target 1
CD44
Gene ID
UniProt ID
Alternative Names
CD44; CD44 antigen; ECMRIII; Extracellular matrix receptor III; HCAM; Homing cell adhesion molecule; Pgp-1; phagocytic glycoprotein-1; HUTCH-1; Ly-24; Pgp-1; HERMES; AU023126; AW121933; AW146109
Target 2
CR3
Gene ID
UniProt ID
Alternative Names
C3AR1; complement C3a receptor 1; AZ3B; C3AR; HNFAG09; CR3; Complement receptor type 3; CD11b/CD18; Mac-1; Macrophage antigen 1; αmβ2
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Online Inquiry
USA
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

UK
167-169 Great Portland Street, 5th Floor, London, W1W 5PE
Tel: 44-207-097-1828
Email:
Related products of "CD44 & CR3"
24x7 CUSTOMER SERVICE
Easy access to products and services you need from our library via
powerful searching tools
© 2021 Creative-Biolabs All Rights Reserved.
Distributors
To view the contact information for a specific location,
select your country or region: